Article ID Journal Published Year Pages File Type
10051891 The Journal of Urology 2005 6 Pages PDF
Abstract
CAB with bicalutamide is cost-effective when compared with LH-RH monotherapy in men with stage D2 prostate cancer.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Preview
THE COST-EFFECTIVENESS OF COMBINED ANDROGEN BLOCKADE WITH BICALUTAMIDE AND LUTEINIZING HORMONE RELEASING HORMONE AGONIST IN MEN WITH METASTATIC PROSTATE CANCER
Authors
, , , , , ,